280 related articles for article (PubMed ID: 16791800)
1. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Nucl Med Rev Cent East Eur; 2006; 9(1):24-9. PubMed ID: 16791800
[TBL] [Abstract][Full Text] [Related]
2. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Maecke H; Kozak J; Michalski A; Rzeszutek K; Kuśmierek J
Cancer Biother Radiopharm; 2004 Oct; 19(5):613-20. PubMed ID: 15650454
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Maecke HR; Michalski A; Rzeszutek K; Kozak J; Kuśmierek J
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1005-10. PubMed ID: 15029463
[TBL] [Abstract][Full Text] [Related]
5. Short communication: Semiquantitative assessment of 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules--a complementary role to visual analysis.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Cancer Biother Radiopharm; 2006 Feb; 21(1):61-7. PubMed ID: 16480332
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: the effect of tumour size on the optimal method of image assessment.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1041-7. PubMed ID: 16715455
[TBL] [Abstract][Full Text] [Related]
7. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
Trogrlic M; Tezak S
Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
[TBL] [Abstract][Full Text] [Related]
9. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
10. Limitations and pitfalls of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) scintigraphy.
Garai I; Barna S; Nagy G; Forgacs A
Nucl Med Rev Cent East Eur; 2016; 19(2):93-8. PubMed ID: 27479887
[TBL] [Abstract][Full Text] [Related]
11. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
Axelsson R; Herlin G; Bååth M; Aspelin P; Kölbeck KG
Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
Hubalewska-Dydejczyk A; Fröss-Baron K; Mikołajczak R; Maecke HR; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybiński P; Kulig J
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1123-33. PubMed ID: 16721571
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.
Decristoforo C; Mather SJ; Cholewinski W; Donnemiller E; Riccabona G; Moncayo R
Eur J Nucl Med; 2000 Sep; 27(9):1318-25. PubMed ID: 11007513
[TBL] [Abstract][Full Text] [Related]
14. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke HR; Biersack HJ
Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
16. The utility of two somatostatin analog radiopharmaceuticals in assessment of radiologically indeterminate pulmonary lesions.
Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Saranovic DZ; Jaksic ED; Subotic D; Nagorni-Obradovic L; Kozarevic N; Petrovic N; Grozdic IT; Obradovic VB
Clin Nucl Med; 2012 Jan; 37(1):14-20. PubMed ID: 22157022
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of 99mTc-depreotide and 201Tl chloride single photon emission tomography in the characterization of pulmonary lesions.
Boundas D; Karatzas N; Moralidis E; Arsos G; Drevelengas A; Pistevou-Gompaki K; Karakatsanis C
Nucl Med Commun; 2007 Jul; 28(7):533-40. PubMed ID: 17538394
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
[TBL] [Abstract][Full Text] [Related]
19. [Fusion of pulmonary scintigraphy with Tc99m-depreotide imaging with CT scan in recognizing solitary pulmonary nodule].
Szaluś N; Chciałowski A; From S; Zagrodzka M; Pietrzykowski J; Dziuk E
Pol Merkur Lekarski; 2008 Oct; 25(148):330-4. PubMed ID: 19145931
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor scintigraphy with 99mTc-Depreotide (NeoSpect) in discriminating between malignant and benign lesions in the diagnosis of lung cancer: a pilot study.
Bååth M; Kölbeck KG; Danielsson R
Acta Radiol; 2004 Dec; 45(8):833-9. PubMed ID: 15690613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
